Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Three-Month DAPT Post-PCI Demonstrates Low Adverse Event Rate in High-Bleeding Risk Patients
News | Antiplatelet and Anticoagulation Therapies | September 30, 2019

September 30, 2019 – Data from the EVOLVE Short DAPT study found that shortened three-month...

Brilinta Monotherapy Reduces Clinically Relevant Bleeding Risk Post-PCI in High-Risk Patients
News | Antiplatelet and Anticoagulation Therapies | September 26, 2019

September 26, 2019 — New data from the Phase IV independent TWILIGHT trial showed...

FDA Grants Fast Track Designation for Farxiga in Heart Failure
News | Heart Failure | September 18, 2019

September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track...

PARAGON-HF Misses Endpoint in Preserved Heart Failure
News | Heart Failure | September 11, 2019

September 11, 2019 — The angiotensin...

Prasugrel Cuts Ischemic Events in Acute Coronary Syndrome Patients
News | Antiplatelet and Anticoagulation Therapies | September 09, 2019

September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary...

Farxiga Significantly Reduces Cardiovascular Death and Worsening of Heart Failure
News | Heart Failure | September 09, 2019

September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF...

Dapagliflozin, Forxiga, was found to help improve outcomes in heart failure patients with reduced ejection fraction (HFrEF) at ESC 2019. #ESC19 #ESC2019
News | Heart Failure | September 09, 2019

September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart...

Entresto Improved Measures of Heart Structure and Function in Heart Failure Patients
News | Heart Failure | September 04, 2019

September 4, 2019 – Novartis announced results from two new...

Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019

August 27, 2019 — Imagine there were a drug that you could take soon after a...

Overlay Init